Senior Manager, Regulatory Affairs US & Canada Strategy Lead – Aesthetics Device (Hybrid)
AbbVie
Summary
The Senior Manager, Regulatory Affairs US & Canada Strategy Lead – Aesthetics Device is responsible for the development and implementation of US and Canada regulatory strategic and tactical planning (RSTP) for assigned on market products or those products in development. This individual combines knowledge of scientific, regulatory & business issues to enable development and commercialization of products that meet relevant US and Canada regulatory requirements, and assures that regulatory strategies defined within the Global Regulatory Product Team (GRPT) are effectively implemented and maintained in line with changing regulatory and business needs.
Job description
Responsibilities
- Has responsibility for products/multiple driver indications for a product within a Therapeutic Area and supports the Global Regulatory Lead (GRL) in the development & execution of the regulatory strategy.
- Leads total product lifecycle activities, including product/manufacturing change assessments, post-approval requirements, addressing Health Authority information requests, annual reporting, and internal regulatory requests.
- Manages interface with Health Authority (FDA) for key projects/issues, including direct collaboration with review division personnel.
- May serve as primary liaison and interface with FDA for meetings, teleconferences and coordinates preparation of FDA meeting briefing packages and responses.
- Advises internal customers who may contribute to regulated communication on Regulatory/FDA issues including Public Affairs, Clinical Development, Legal, and Commercial.
- Operates independently, with recognition of when to consult management; makes decisions and plans for operations within area of responsibility with minimal direction.
- Coordinates, prepares and/or supervises the preparation and review of regulatory submissions consistent with US and Canada regulatory requirements and guidelines and assures complete and timely response to Health Authorities during application review.
- Ensures application of established policies and best practice regulatory standards for all US/Canada product registrations.
- Demonstrates understanding of current US and Canada regulations and guidance, political and legal climate and industry practices to assist in meeting organizational goals.
- Broadly applies regulatory/technical knowledge of government regulations and skills across therapeutic areas.
- Presents pertinent regulatory information to appropriate cross-functional teams.
- Operates in compliance with regulations, company policies, procedures, and guidance in alignment with regulatory product strategy and the Quality Dossier Program (QDP).
Requirements
- Advanced degree (e.g. PharmD, PhD, MS) or Regulatory certification
- 5+ years Regulatory, R&D, or equivalent industry-related experience
- Experience in medical device space
- Experience with digital health/software
- Proven skill at implementing successful affiliate regulatory strategies (US or Canada experience preferred)
- Experience working in a complex and matrix environment
- Experience interfacing with government regulatory agencies
- Demonstrates excellent negotiation skills, problem solving skills and builds consensus
- Demonstrates effective communication skills in written and oral channels both within Regulatory and across the organization
- Able to deliver challenging messages effectively without compromising important business relationships
Benefits
- Paid time off
- Medical, Dental & Vision
- 401(k)
- Long-term incentive programs
Company overview
AbbVie is a global biopharmaceutical company that discovers, develops, and markets advanced therapies for some of the world's most complex and serious diseases. Founded in 2013 as a spin-off from Abbott Laboratories, AbbVie has established itself as a leader in immunology, oncology, neuroscience, eye care, and virology. The company's flagship product, Humira (adalimumab), was one of the world's top-selling drugs for treating autoimmune conditions like rheumatoid arthritis and Crohn's disease. AbbVie maintains a robust pipeline of innovative medicines and has expanded its portfolio through strategic acquisitions, including Allergan in 2020. With research facilities across the United States and globally, AbbVie focuses on advancing science to improve patient outcomes while maintaining strong commercial operations worldwide. The company operates with a patient-centric approach and invests significantly in research and development to address unmet medical needs across multiple therapeutic areas.